[1] RAGHU G,WEYCKER D,EDELSBERG J,et al. Incidence and prevalence of idiopathic pulmonary fibrosis[J]. Am J Respir and Crit Care Med,2006,174(7):810-816.
[2] 蒋云峰.黄芪桃红汤治疗特发性肺纤维化24例[J].吉林中医药,2003,23(11):14.
[3] 李丽君,范盎然,葛东宇,等.黄芪当归对药对特发性肺纤维化小鼠生存状况及组织修复相关基因表达水平的影响[J].环球中医药,2015,8(12):1441-1445.
[4] 李红,王胜,沈明霞,等.黄芪甲苷对特发性肺纤维化模型大鼠肺组织碱性成纤维细胞生长因子(bFGF)表达的影响[J].西部中医药,2015,28(12):21-24.
[5] 李红,沈明霞,谢海彬,等.黄芪甲苷对特发性肺纤维化模型大鼠肺组织CD34表达的影响[J].西部中医药,2015,28(9):6-10.
[6] PRASSE A,PECHKOVSKY D V,TOEWS G B,et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis[J]. Arthriti Rheumat,2007,56(5):1685-1693.
[7] CAI M,BONELLA F,HE X,et al. CCL18 in serum,BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases[J]. Respir Med,2013,107(9):1444-1452.
[8] PRASSE A,PROBST C,BARGAGLI E,et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Me,2009,179(8):717-723.
[9] HIESHIMA K,IMAI T,BABA M,et al. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes,but not for monocytes[J]. J Immunol,1997,159(3):1140-1149.
[10] Kodelja V,Müller C,Politz O,et al. Alternative macrophage activation-associated CC-chemokine-1,a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern.[J]. J Immunol,1998,160(3):1411-1418.
[11] PRASSE A,PECHKOVSKY D V,TOEWS G B,et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18[J]. Am J Respi Crit Care Med,2006,173(7):781-792.
[12] PECHKOVSKY D V,PRASSE A,KOLLERT F,et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction[J]. Clin Immunol,2010,137(1):89-101.
[13] ANDO M,MIYAZAKI E,FUKAMI T,et al. Interleukin-4-producing cells in idiopathic pulmonary fibrosis:an immunohistochemical study[J]. Respirology,1999,4(4):383-391.
[14] WALLACE W A,HOWIE S E. Immunoreactive interleukin 4 and interferon gamma expression by type Ⅱ alveolar epithelial cells in interstitial lung disease[J].J Pathol,1999,187(4):475-480.
[15] SCHUTYSER E,RICHMOND A,DAMME J V. Involvement of CC chemokine ligand 18(CCL18) in normal and pathological processes[J]. J Leuk Biol,2005,78(1):14-26.
[16] ATAMAS S P,LUZINA I G,CHOI J,et al. Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts[J]. Am J Respir Cell Mol Biol,2003,29(6):743-749.
[17] LUZINA I G,PAPADIMITRIOU J C,ANDERSON R,et al. Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18[J]. Arthr Rheum,2006,54(8):2643-2655.
[18] LUZINA I G,KEEGAN A D,HELLER N M,et al. Regulation of inflammation by interleukin-4:a review of "alternatives"[J]. J Leuk Biol,2012,92(4):753-764.